Genscript Biotech Corporation (1548.HK)

HKD 10.4

(-0.57%)

Revenue Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual revenue in 2023 was 839.52 Million USD , up 34.17% from previous year.
Genscript Biotech Corporation's latest quarterly revenue in 2024 Q2 was 561.37 Million USD , up 25.25% from previous quarter.
Genscript Biotech Corporation reported a annual revenue of 625.69 Million USD in annual revenue 2022, up 27.67% from previous year.
Genscript Biotech Corporation reported a annual revenue of 490.09 Million USD in annual revenue 2021, up 25.39% from previous year.
Genscript Biotech Corporation reported a quarterly revenue of 391.31 Million USD for 2023 Q2, up 23.79% from previous quarter.
Genscript Biotech Corporation reported a quarterly revenue of 448.21 Million USD for 2023 Q4, up 14.54% from previous quarter.

Annual Revenue Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Revenue of Genscript Biotech Corporation (2023 - 2013)

Year	Revenue	Revenue Growth
2023	839.52 Million USD	34.17%
2022	625.69 Million USD	27.67%
2021	490.09 Million USD	25.39%
2020	390.84 Million USD	42.98%
2019	273.35 Million USD	18.33%
2018	231.01 Million USD	51.34%
2017	152.64 Million USD	33.04%
2016	114.73 Million USD	32.32%
2015	86.7 Million USD	23.88%
2014	69.99 Million USD	16.45%
2013	60.1 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	561.37 Million USD	25.25%
2023 Q2	391.31 Million USD	23.79%
2023 Q4	448.21 Million USD	14.54%
2023 FY	839.52 Million USD	34.17%
2022 FY	625.69 Million USD	27.67%
2022 Q4	316.1 Million USD	2.11%
2022 Q2	309.58 Million USD	18.83%
2021 FY	490.09 Million USD	25.39%
2021 Q4	260.52 Million USD	13.49%
2021 Q2	229.56 Million USD	2.28%
2020 Q2	166.39 Million USD	9.85%
2020 FY	390.84 Million USD	42.98%
2020 Q4	224.45 Million USD	34.89%
2019 FY	273.35 Million USD	18.33%
2019 Q4	151.47 Million USD	24.28%
2019 Q2	121.87 Million USD	2.59%
2018 Q4	118.79 Million USD	5.86%
2018 Q2	112.22 Million USD	25.72%
2018 FY	231.01 Million USD	51.34%
2017 Q4	89.26 Million USD	40.82%
2017 FY	152.64 Million USD	33.04%
2017 Q2	63.38 Million USD	3.01%
2016 Q2	53.2 Million USD	16.52%
2016 Q4	61.53 Million USD	15.67%
2016 FY	114.73 Million USD	32.32%
2015 Q4	45.65 Million USD	11.23%
2015 Q2	41.05 Million USD	12.55%
2015 FY	86.7 Million USD	23.88%
2014 Q4	36.47 Million USD	8.81%
2014 Q2	33.52 Million USD	91.56%
2014 FY	69.99 Million USD	16.45%
2013 Q4	17.49 Million USD	0.0%
2013 FY	60.1 Million USD	0.0%

Peer Revenue Comparison of Genscript Biotech Corporation

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-73.199%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	84.227%